Literature DB >> 19367505

Basic neuroanatomy and neuropharmacology of cannabinoids.

Chris S Breivogel1, Laura J Sim-Selley.   

Abstract

Humans have used Cannabis sativa (marijuana) for at least 12,000 years, but researchers have only recently described an endogenous cannabinoid system. The endocannabinoid system modulates an array of physiological and psychological functions. Endocannabinoids are widely distributed throughout the body, including the central nervous system (CNS). This article gives a basic overview of endocannabinoid neuroanatomy and function. Several endocannabinoids have been discovered to date, and their roles are being elucidated. Two G-protein coupled cannabinoid receptors, CB1R and CB2R, have been identified, although other candidate receptors exist, including ion channel and nuclear receptors that might be components of the endocannabinoid system. It appears that cannabinoids are dysregulated in a number of psychiatric disorders and might be involved in their pathogenesis. There is now evidence that manipulation of the endocannabinoid system could be a therapeutic target for a variety of conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367505     DOI: 10.1080/09540260902782760

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  11 in total

Review 1.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  The role of androgen receptor in transcriptional modulation of cannabinoid receptor type 1 gene in rat trigeminal ganglia.

Authors:  K S Lee; J Asgar; Y Zhang; M-K Chung; J Y Ro
Journal:  Neuroscience       Date:  2013-09-17       Impact factor: 3.590

Review 3.  Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.

Authors:  Maria Scherma; Anna Lisa Muntoni; Miriam Melis; Liana Fattore; Paola Fadda; Walter Fratta; Marco Pistis
Journal:  Psychopharmacology (Berl)       Date:  2016-01-04       Impact factor: 4.530

Review 4.  Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia.

Authors:  Concepción García; Cristina Palomo-Garo; Yolanda Gómez-Gálvez; Javier Fernández-Ruiz
Journal:  Br J Pharmacol       Date:  2015-07-31       Impact factor: 8.739

5.  Endocannabinoid-Binding Receptors as Drug Targets.

Authors:  María Gómez-Cañas; Carmen Rodríguez-Cueto; Valentina Satta; Inés Hernández-Fisac; Elisa Navarro; Javier Fernández-Ruiz
Journal:  Methods Mol Biol       Date:  2023

6.  ΔFosB induction correlates inversely with CB₁ receptor desensitization in a brain region-dependent manner following repeated Δ⁹-THC administration.

Authors:  Matthew F Lazenka; Dana E Selley; Laura J Sim-Selley
Journal:  Neuropharmacology       Date:  2013-09-30       Impact factor: 5.250

7.  Cannabinoid agonist rescues learning and memory after a traumatic brain injury.

Authors:  Marium Arain; Maida Khan; Laura Craig; Stan T Nakanishi
Journal:  Ann Clin Transl Neurol       Date:  2015-02-16       Impact factor: 4.511

8.  Cannabinoids: well-suited candidates for the treatment of perinatal brain injury.

Authors:  David Fernández-López; Ignacio Lizasoain; Maria Angeles Moro; José Martínez-Orgado
Journal:  Brain Sci       Date:  2013-07-10

Review 9.  Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review.

Authors:  Luca Steardo; Elvira Anna Carbone; Giulia Menculini; Patrizia Moretti; Luca Steardo; Alfonso Tortorella
Journal:  Life (Basel)       Date:  2021-03-09

10.  Lifestyle Interventions Improving Cannabinoid Tone During COVID-19 Lockdowns May Enhance Compliance With Preventive Regulations and Decrease Psychophysical Health Complications.

Authors:  Viola Brugnatelli; Enrico Facco; Gastone Zanette
Journal:  Front Psychiatry       Date:  2021-07-16       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.